Psychological Trauma, Post-Traumatic Stress Disorder, and Resilience in Adults With Congenital Heart Disease
PTSD in ACHD
1 other identifier
observational
1,000
1 country
3
Brief Summary
The purpose of this study, entitled "Psychological trauma, post-traumatic stress disorder, and resilience in adults with congenital heart disease in a large population sample", is to evaluate for exposures during a lifetime with congenital heart disease that may be associated with higher likelihood of developing PTSD. Primary aim: \- Identify individual patient characteristics (medical, psychosocial, socioeconomic, etc.) that are associated with a diagnosis of PTSD. Secondary aims:
- Calculate the prevalence of those meeting PTSD criteria in the ACHD population using the "gold standard" diagnostic clinician interview, while using the same data to validate a PTSD screening self-report survey in the ACHD population.
- Determine the role of resilience in ACHD patients using a validated screening survey to assess its protective role toward PTSD. Hypotheses:
- There are certain exposures (e.g. post-surgical pain, ICU delirium, bullying due to CHD) that are associated with a higher incidence and odds of meeting PTSD criteria.
- "Gold standard" diagnostic interviews will most accurately estimate the prevalence of PTSD in ACHD which has been overestimated on prior screening-based studies, although the scope of the problem is still great.
- Patients with a higher resilience score will show an association with a lower risk of PTSD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2025
Shorter than P25 for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 8, 2025
CompletedFirst Posted
Study publicly available on registry
May 1, 2025
CompletedStudy Start
First participant enrolled
September 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 1, 2026
March 25, 2026
June 1, 2025
9 months
January 8, 2025
March 23, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
PTSD checklist for DSM-5 (PCL-5)
A 20-item survey of the five domains of PTSD as described by the DSM-5. Each item is on a five-point Likert scale describing severity of symptoms (bothered by symptoms "not at all" to "extremely"). Each item is graded 0 to 4, for a total PCL-5 score ranging from 0 to 80. Historical studies have recommended a cutoff for PTSD-positive around 31 to 33. This study will attempt to validate the proper cutoff in the ACHD population using the diagnostic interview.
One-time survey. Distribute to patients during months ~1-2.
Secondary Outcomes (2)
Clinician Administered PTSD Scale Diagnostic Interview (CAPS-5)
One-time interview during study months 4 to 12
Connor-Davidson Resilience Scale (CD-RISC)
One-time survey. Distribute to patients during months ~1-2.
Study Arms (1)
Overall cohort
Adults age \>= 18-years with a diagnosis of congenital heart disease. Congenital heart disease will be defined by previously published classification including those listed in the American Heart Association/ American College of Cardiology guidelines for the care of adults with congenital heart disease.
Interventions
Surveys will be distributed for data collection. A subset of patients will participate in diagnostic clinician interviews. No interventions will be tested.
Eligibility Criteria
Any adult with a congenital heart disease diagnosis
You may qualify if:
- Congenital heart disease diagnosis, age \>= 18 years
- Enrolled in CHI registry
- English proficiency for survey completion
- Access to an internet connection. Can be via computer or handheld device.
You may not qualify if:
- Any who opt out
- Age \< 18 years
- No diagnosis of congenital heart disease
- Not enrolled in CHI registry/unable to access Internet
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Children's National Medical Center
Washington D.C., District of Columbia, 20010, United States
Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire, 03766, United States
Nationwide Children's Hospital
Columbus, Ohio, 43205, United States
Related Publications (4)
Webb G, Landzberg MJ, Daniels CJ. Specialized adult congenital heart care saves lives. Circulation. 2014 May 6;129(18):1795-6. doi: 10.1161/CIRCULATIONAHA.114.009049. Epub 2014 Mar 3. No abstract available.
PMID: 24589850BACKGROUNDSteiner JM, Nassans K, Brumback L, Stout KK, Longenecker CT, Yi-Frazier JP, Curtis JR, Rosenberg AR. Key Psychosocial Health Outcomes and Association With Resilience Among Patients With Adult Congenital Heart Disease. JACC Adv. 2024 May;3(5):100917. doi: 10.1016/j.jacadv.2024.100917. Epub 2024 Mar 28.
PMID: 38846320BACKGROUNDPhillippi R, Leezer S, Messmer M, Hile D, John AS. Patient Engagement in Research: Considerations in Creating a Registry for Adults with Congenital Heart Disease. Curr Cardiol Rep. 2024 Jan;26(1):15-21. doi: 10.1007/s11886-023-02013-2. Epub 2023 Dec 22.
PMID: 38133788BACKGROUNDHarrison DJ, Kay J, Jacobsen RM, Londono-Obregon C, Yeung E, Kelly SL, Poteet A, Levek C, Landzberg MJ, Wallrich M, Khanna A. The burden of psychological trauma and post-traumatic stress disorder among adults with congenital heart disease: PTSD in ACHD. Am J Cardiol. 2024 May 15;219:9-16. doi: 10.1016/j.amjcard.2024.03.007. Epub 2024 Mar 6.
PMID: 38458583BACKGROUND
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 3 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
January 8, 2025
First Posted
May 1, 2025
Study Start
September 1, 2025
Primary Completion (Estimated)
June 1, 2026
Study Completion (Estimated)
August 1, 2026
Last Updated
March 25, 2026
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share
This study is not a clinical trial and does not have an intervention group. Some data collected will be on sensitive topics. No current plan to share data with other researchers.